Zepp Health Corporation
Informe acción NYSE:ZEPP
Capitalización de mercado: US$48.9m
Zepp Health Resultados de beneficios anteriores
Pasado controles de criterios 0/6 Los beneficios de Zepp Health han disminuido a una tasa media anual de -64.4%, mientras que en la industria Electronic los beneficios crecieron en un 14.2% anualmente. Los ingresos han ido disminuyendo a una tasa media de 15.6% al año.
Información clave
-64.4%
Tasa de crecimiento de los beneficios
-64.8%
Tasa de crecimiento del BPA
Crecimiento de la industria Electronic 15.3% Tasa de crecimiento de los ingresos -15.6% Rentabilidad financiera -7.7% Margen neto -10.4% Próxima actualización de resultados 18 Nov 2024
Actualizaciones de resultados anteriores recientes
Zepp Health Corporation to Report Q3, 2024 Results on Nov 18, 2024 Nov 05
Second quarter 2024 earnings released: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023) Aug 22
Zepp Health Corporation to Report Q2, 2024 Results on Aug 21, 2024 Aug 08
Zepp Health Corporation to Report Q1, 2024 Results on May 20, 2024 May 10
Full year 2023 earnings: EPS and revenues miss analyst expectations Apr 25
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 19
Mostrar todas las actualizaciones
Zepp Health Corporation to Report Q3, 2024 Results on Nov 18, 2024 Nov 05
Zepp Health Regains Compliance with NYSE Minimum Price Continued Listing Criterion Oct 03
Zepp Health Corporation Announces Board Changes Sep 04
Zepp Health Corporation Announces Board Changes, Effective from September 1, 202 Sep 03
Consensus revenue estimates fall by 32% Aug 29
Second quarter 2024 earnings released: US$0.17 loss per share (vs US$0.16 loss in 2Q 2023) Aug 22
Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2024 Aug 22
New minor risk - Share price stability Aug 20
Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry Aug 20
Now 25% overvalued Aug 13
Zepp Health Corporation to Report Q2, 2024 Results on Aug 21, 2024 Aug 08
Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP) Aug 03
Price target increased by 30% to US$5.19 Jul 12
Now 22% overvalued Jul 02
Zepp Health Corporation Introduces Zepp OS 4 Jul 02
New major risk - Revenue and earnings growth May 26
Zepp Health Corporation to Report Q1, 2024 Results on May 20, 2024 May 10 Zepp Health Announces US Launch Date for Amazfit Helio Ring
Full year 2023 earnings: EPS and revenues miss analyst expectations Apr 25
Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough Apr 17
Consensus EPS estimates fall by 97% Mar 25
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 19
Zepp Health Corporation to Report Q4, 2023 Results on Mar 18, 2024 Mar 08
Zepp Health Unveils the Amazfit Helio Ring for Optimum Athletic Performance at CES 2024 Jan 10
Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30% Dec 23
New minor risk - Share price stability Dec 02
Price target increased by 29% to US$3.99 Nov 24
Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales Nov 24
Third quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.28 loss in 3Q 2022) Nov 24
Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2023 Nov 22
Zepp Health Corporation to Report Q3, 2023 Results on Nov 20, 2023 Nov 08
Zepp Health Corporation Launches Amazfit Balance with AI-Empowered Features for the Ultimate in Balanced Living Sep 02
Zepp Health Corporation Provides Revenue Guidance for the Third Quarter of 2023 Aug 23
Second quarter 2023 earnings released: CN¥1.15 loss per share (vs CN¥1.74 loss in 2Q 2022) Aug 22
Zepp Health Corporation to Report Q2, 2023 Results on Aug 21, 2023 Aug 10
Zepp Health Corporation Announces Amazfit Makes the New Amazfit Bip 5 Globally Available Aug 03
Can Zepp Health Find Its Way Back Up? Jul 31
Amazfit Launches New Amazfit Cheetah Series Jun 22
Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2023 May 25
First quarter 2023 earnings released: CN¥2.23 loss per share (vs CN¥1.42 loss in 1Q 2022) May 24
Zepp Health Corporation to Report Q1, 2023 Results on May 23, 2023 May 11
Full year 2022 earnings released: CN¥4.68 loss per share (vs CN¥2.19 profit in FY 2021) Mar 23
Third quarter 2022 earnings released: CN¥0.28 loss per share (vs CN¥0.78 profit in 3Q 2021) Nov 23
Zepp Health Corporation Provides Revenue Guidance for the Fourth Quarter of 2022 Nov 22
Amazfit Launches Challenge on Adidas Apps Following Partnership Announcement Nov 17
Price target decreased to US$2.75 Nov 16
Less than half of directors are independent Nov 16
Zepp Health Corporation to Report Q3, 2022 Results on Nov 21, 2022 Nov 09
Amazfit Unveils Next-Level Sports and Lifestyle Experiences with the New Amazfit GTR 4 and GTS 4 Smartwatches Sep 02
Second quarter 2022 earnings released: CN¥1.74 loss per share (vs CN¥1.47 profit in 2Q 2021) Aug 27
Zepp Health Corporation Provides Earnings Guidance for the Third Quarter of 2022 Aug 26
Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M Aug 25
Investor sentiment improved over the past week Aug 12
What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate? Aug 12
Zepp Health Corporation to Report Q2, 2022 Results on Aug 25, 2022 Aug 12 Amazfit Launches its Latest Firmware Update for OTS Rugged Outdoor GPS Smartwatch, the Amazfit T-Rex 2
Amazfit Unveils Newest Compact and Power-Packed Smartwatch, the Amazfit GTS 4 Mini Jul 12
Amazfit Sends the Super-Tough T-Rex 2 Smartwatch on A Space Ride Jul 02
Amazfit Introduces Best-Value Essential Smartwatch Additions, the Amazfit Bip 3 and Bip 3 Pro Jun 16
Zepp Health Corporation, Annual General Meeting, Jul 05, 2022 Jun 15
Zepp: Speculative, But With Potentially Great Rewards Jun 08
Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022 May 25
Price target decreased to US$5.53 May 25
Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2022 May 25 Zepp Health Corporation to Report Q1, 2022 Results on May 24, 2022 May 10
Full year 2021 earnings released: EPS: CN¥2.19 (vs CN¥3.68 in FY 2020) May 01
Less than half of directors are independent Apr 28
Full year 2021 earnings: Revenues miss analyst expectations Mar 18
What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate? Mar 16
Investor sentiment deteriorated over the past week Mar 12
Zepp Health Corporation to Report Q4, 2021 Results on Mar 17, 2022 Mar 03
Investor sentiment deteriorated over the past week Feb 24
Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value? Feb 23
Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh Jan 06
Zepp Health Corp. Provides Guidance for the Fourth Quarter of 2021 Jan 01
Investor sentiment deteriorated over the past week Dec 18
When Should You Buy Zepp Health Corporation (NYSE:ZEPP)? Dec 15
Investor sentiment deteriorated over the past week Dec 04
Third quarter 2021 earnings released Nov 18
Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist Oct 28
Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch Oct 15
Price target decreased to US$13.00 Oct 13
Zepp: A Solid International Diversification Play Oct 03
Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)? Sep 13
Second quarter 2021 earnings released: EPS CN¥1.47 (vs CN¥0.21 in 2Q 2020) Aug 21
Zepp Health Corporation Provides Earnings Guidance for the Third Quarter of 2021 Aug 21
Price target increased to US$16.86 Aug 19
Investor sentiment improved over the past week Aug 04 Zepp Health Corp. Introduces Next Gen Smart Wearable Chip, Smartwatch OS and Blood Pressure Measurement At Annual Developers Conference
Zepp Health: Taking Over The Smart Health Wearables Market Jul 14
We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt Jul 07
Chief Operating Officer notifies of intention to sell stock Jun 24
Returns On Capital Are Showing Encouraging Signs At Zepp Health (NYSE:ZEPP) May 31
Investor sentiment improved over the past week May 21
Zepp Health Corporation Provides Revenue Guidance for the Second Quarter of 2021 May 15
Desglose de ingresos y gastos
Cómo gana y gasta dinero Zepp Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos NYSE:ZEPP Ingresos, gastos y beneficios (USD Millions) Fecha Ingresos Beneficios Gastos G+A Gastos de I+D 30 Jun 24 237 -25 64 44 31 Mar 24 296 -25 68 47 31 Dec 23 352 -30 71 51 30 Sep 23 406 -38 77 54 30 Jun 23 492 -41 85 62 31 Mar 23 587 -49 98 71 31 Dec 22 601 -42 101 75 30 Sep 22 665 -25 103 70 30 Jun 22 766 -16 106 71 31 Mar 22 924 14 111 80 31 Dec 21 983 22 110 81 30 Sep 21 1,017 34 103 85 30 Jun 21 1,114 38 111 95 31 Mar 21 991 26 102 87 31 Dec 20 986 35 95 82 30 Sep 20 968 47 86 81 30 Jun 20 877 63 71 71 31 Mar 20 861 73 66 67 31 Dec 19 835 82 62 62 30 Sep 19 689 67 53 53 30 Jun 19 603 57 51 45 31 Mar 19 575 58 47 39 31 Dec 18 530 16 45 38 30 Sep 18 462 4 39 33 30 Jun 18 389 -10 30 30 31 Mar 18 367 -22 29 30 31 Dec 17 315 7 24 24 30 Sep 17 287 8 24 21 31 Dec 16 224 -2 19 19 31 Dec 15 138 -9 14 9
Ingresos de calidad: ZEPP actualmente no es rentable.
Margen de beneficios creciente: ZEPP actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ZEPP no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 64.4% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de ZEPP en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: ZEPP no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Electronic (-1.8%).
Rentabilidad financiera
Alta ROE: ZEPP tiene una rentabilidad financiera negativa (-7.68%), ya que actualmente no es rentable.
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
